Citigroup’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24.9K | Sell |
|
|||||
|
2025
Q2 | $73.1K | Sell |
|
|||||
|
2025
Q1 | $111K | Sell |
|
|||||
|
2024
Q4 | $224K | Buy |
|
|||||
|
2024
Q3 | $216K | Buy |
|
|||||
|
2024
Q2 | $161K | Sell |
|
|||||
|
2024
Q1 | $983K | Buy |
|
|||||
|
2023
Q4 | $45.3K | Buy |
|
|||||
|
2023
Q3 | $132 | Sell |
|
|||||
|
2023
Q2 | $109K | Sell |
|
|||||
|
2023
Q1 | $660K | Buy |
|
|||||
|
2022
Q4 | $513K | Buy |
|
|||||
|
2022
Q3 | $19K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $186K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $5K | Sell |
|
|||||
|
2021
Q2 | $9K | Sell |
|
|||||
|
2021
Q1 | $12K | Sell |
|
|||||
|
2020
Q4 | $120K | Buy |
|
|||||
|
2020
Q3 | $99K | Sell |
|
|||||
|
2020
Q2 | $310K | Sell |
|
|||||
|
2020
Q1 | $289K | Buy |
|
|||||
|
2019
Q4 | $298K | Sell |
|
|||||
|
2019
Q3 | $1.27M | Sell |
|
|||||
|
2019
Q2 | $2.23M | Buy |
|
|||||
|
2019
Q1 | $706K | Sell |
|
|||||
|
2018
Q4 | $1.14M | Buy |
|
|||||
|
2018
Q3 | $1.23M | Buy |
|
|||||
|
2018
Q2 | $870K | Buy |
|
|||||
|
2018
Q1 | $670K | Buy |
|
|||||
|
2017
Q4 | $191K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1K | Buy |
|
|||||
|
2017
Q1 | $0 | Sell |
|
|||||
|
2016
Q4 | $23K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $13K | Sell |
|
|||||
|
2016
Q1 | $41K | Buy |
|
|||||
|
2015
Q4 | $38K | Buy |
|